Steve is an experienced private equity and development capital specialist having enjoyed a successful 30+ year career with the UK’s two leading mid-market private equity companies, and a specialist fund investing in the creative industries. He currently sits on the Boards of Metrion Biosciences and CitySwift on behalf of Gresham House Ventures.

After completing a law degree at Edinburgh University in 1991, Steve joined 3i where he worked in their Edinburgh and Cambridge offices.  In 1999 he left 3i to join LDC, the private equity arm of Lloyds Banking Group.  When Steve left LDC at the end of 2010, it had grown to become the UK’s leading mid-market private equity investor, and the deals which Steve led delivered near 100% gains on funds invested. After 5 years consulting and pursuing his own private investment activities, Steve joined Edge Investments, the UK’s leading creative industries investor where he served as both Chief Investment Officer and Portfolio Performance Director.  Returning to his consulting activities in 2021, Steve has worked with a number of PE investors, primarily in roles involving management of portfolio companies.

Example portfolio